In March 2025, the company declared new programs for the direct-to-purchaser offering of its Wegovy weight loss drug. The company established a brand new pharmacy, known as NovoCare, which would cost customers $499 each month for access to the drug, fewer than half the expense of the drug via other pharmaceutical distribution networks.[53]But Rybel